{"id":"NCT00143403","sponsor":"Pfizer","briefTitle":"Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer","officialTitle":"Multi-Centre Phase III Open Label Randomized Trial Comparing CPT-11 In Combination With A 5-FU/FA Infusional Regimen To The Same 5-FU/FA Infusional Regimen Alone, As Adjuvant Treatment After Resection Of Liver Metastases For Colorectal Cancer.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-12","primaryCompletion":"2008-02","completion":"2009-09","firstPosted":"2005-09-02","resultsPosted":"2009-06-01","lastUpdate":"2010-09-28"},"enrollment":321,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Colorectal Neoplasms","Liver Neoplasms"],"interventions":[{"type":"DRUG","name":"Irinotecan + 5 FU + folinic acid","otherNames":[]},{"type":"DRUG","name":"Folinic Acid + 5 FU","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"To see if Disease Free Survival (DFS) is improved when complete surgical resection of liver metastases (R0) is followed by chemotherapy with CPT-11 and 5-FU/FA as FOLFIRI regimen, compared to 5-FU/FA alone.","primaryOutcome":{"measure":"Disease Free Survival (DFS)","timeFrame":"last tumor assessment date or cut-off date, whichever is earlier.","effectByArm":[{"arm":"5-FU/FA","deltaMin":21.6,"sd":null},{"arm":"Irinotecan + 5-FU/FA","deltaMin":24.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"0.468"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":66,"countries":["Belgium","Denmark","France","Germany","Hong Kong","Israel","Italy","Portugal","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=CPT-GMA-301&StudyName=Comparing%20Irinotecan%20and%205%20FU/FA%20To%205-FU/FA%20After%20Resection%20Of%20Liver%20Metastases%20For%20Colorectal%20Cancer"]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":152},"commonTop":["Nausea","Diarrhea, NOS","Asthenia","Vomiting, NOS","Alopecia"]}}